Novo Nordisk A/S (NONOF)
49.02
-0.50
(-1.01%)
USD |
OTCM |
Feb 11, 16:00
Novo Nordisk Market Cap : 217.97B for Feb. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 908.63B |
| Hims & Hers Health, Inc. | 3.799B |
| Genmab A/S | 18.49B |
| Ascendis Pharma A/S | 13.53B |
Market Cap Related Metrics
| PE Ratio | 14.13 |
| PS Ratio | 4.668 |
| PEG Ratio | 2.503 |
| Price to Book Value | 7.144 |
| Price to Free Cash Flow | 48.32 |
| Price | 49.02 |
| Earnings Yield | 7.08% |
| PEGY Ratio | 1.540 |
| Operating PE Ratio | 11.34 |
| Normalized PE Ratio | 14.13 |